IKNA

Ikena Oncology, Inc. - Common Stock (IKNA)

About Ikena Oncology, Inc. - Common Stock (IKNA)

Ikena Oncology, Inc. is a clinical stage biotechnology company, which engages in the development of patient directed and biomarker driven therapies for cancer patients. Its product pipeline includes IK-930, RAS Signaling, IK-175, IK-412, and IK-007. The company was founded by Mark Manfredi and George Georgiou in February 2016 and is headquartered in Boston, MA.

Details

Daily high

$1.40

Daily low

$1.34

Price at open

52 Week High

$1.94

52 Week Low

$0.97

Market cap

65.1M

Dividend yield

0.00%

Volume

100

Avg. volume

52,038

P/E ratio

-1.56

Ikena Oncology, Inc. - Common Stock News